Cover Image
市場調查報告書

全球人體血清蛋白市場與產品平台分析

Analysis of the Global Human Albumin Market and Product Pipeline

出版商 Frost & Sullivan 商品編碼 338819
出版日期 內容資訊 英文 60 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球人體血清蛋白市場與產品平台分析 Analysis of the Global Human Albumin Market and Product Pipeline
出版日期: 2015年09月02日 內容資訊: 英文 60 Pages
簡介

本報告提供全球人體血清蛋白市場相關調查分析,以上市產品、臨床實驗中的產品為焦點,提供臨床實驗的時間軸和結果、實際成果與預測、競爭情形等相關的系統性資訊。

第1章 摘要整理

第2章 調查手法和範圍

第3章 市場背景

  • 市場概要:簡介
  • 市場概要:血漿生產
  • 血漿市場佔有率
  • 血漿蛋白質的需求分析
  • 人體血清蛋白生產
  • 市場預測:人體血清蛋白
  • 供應鏈與流通網路
  • 波特的五力分析
  • 人體血清蛋白市場佔有率分析
  • 市場區隔

第4章 競爭情形 - 人體血清蛋白:上市、開發中產品

  • 競爭情形:上市、開發中產品
  • 上市產品:補充療法
  • 開發中產品:補充療法
  • 上市產品:製劑和藥物遞輸
  • 開發中產品:製劑和藥物遞輸

第5章 樞紐試驗:階段3、階段2

  • 市場整體:持續中/最近完成的臨床實驗
  • 值得注意的主要產品摘要
  • 主要活動的時間軸:產品銷售

第6章 產品開發動態即時看板系統:主要的上市、3階段產品

  • Albuminar (CSL Behring)
  • Albutein (Grifols)
  • Abraxane (Celgene)
  • Victoza (Novo Nordisk)
  • Recombumin (Novozymes)
  • rIX-FP (CSL Behring)

第7章 結論

第8章 關於Frost&Sullivan

目錄
Product Code: MB53-01-00-00-00

Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities

The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented into those used in replacement therapy (fluid-volume replacement therapy), in drug formulation and delivery, as stabilisers for vaccines, and as excipients in imaging and in-vitro fertilisation products. The market shares of the key companies operating in this space have also been listed.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Executive Summary-Key Findings
  • 2. Executive Summary-Key Findings (continued)
  • 3. Key Trends
  • 4. Key Companies to Watch

2. METHODOLOGY AND SCOPE

Methodology and Scope

  • 1. Methodology and Scope

3. MARKET BACKGROUND

Market Background

  • 1. Market Overview-Introduction
  • 2. Market Overview-Blood Plasma Production
  • 3. Blood Plasma Market Share
  • 4. Demand Analysis of Blood Plasma Proteins
  • 5. Human Albumin Production
  • 6. Market Forecast-Human Albumin
  • 7. Market Forecast-Human Albumin Discussion
  • 8. Supply Chain and Distribution Network
  • 9. Supply Chain and Distribution Network (continued)
  • 10. Porter's 5 Forces Analysis
  • 11. Porter's 5 Forces Analysis (continued)
  • 12. Porter's 5 Forces Analysis (continued)
  • 13. Human Albumin Market Share Analysis
  • 14. Market Segmentation

4. COMPETITIVE LANDSCAPE-HUMAN ALBUMIN: MARKETED AND PIPELINE PRODUCTS

Competitive Landscape-Human Albumin: Marketed and Pipeline Products

  • 1. Recommendations for Data Center Operators
  • 2. Competitive Landscape-Marketed and Pipeline Products
  • 3. Marketed Products-Replacement Therapy
  • 4. Marketed Products-Replacement Therapy (continued)
  • 5. Pipeline Products-Replacement Therapy
  • 6. Marketed Products-Drug Formulation and Delivery
  • 7. Marketed Products-Drug Formulation and Delivery (continued)
  • 8. Pipeline Products-Drug Formulation and Delivery
  • 9. Marketed Products-Vaccine
  • 10. Pipeline Products-Vaccine
  • 11. Marketed Products-Others

5. PIVOTAL TRIALS-PHASE 3 AND PHASE 2

Pivotal Trials-Phase 3 and Phase 2

  • 1. Total Human Albumin Market-Major Ongoing/Recently Completed Clinical Trials
  • 2. Summary of Key Products to Watch
  • 3. Timeline of Key Events-Launch of Products

6. PRODUCT DASHBOARD-KEY MARKETED AND PHASE 3 PRODUCTS

Product Dashboard-Key Marketed and Phase 3 Products

  • 1. Product Dashboard: Albuminar-CSL Behring
  • 2. Product Dashboard: Albutein-Grifols
  • 3. Product Dashboard: Abraxane-Celgene
  • 4. Product Dashboard: Victoza-Novo Nordisk
  • 5. Product Dashboard: Recombumin-Novozymes
  • 6. Product Dashboard: rIX-FP-CSL Behring

7. CONCLUSION

Conclusion

  • 1. Conclusions
  • 2. Legal Disclaimer

8. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top